Search results for “Hydrochlorothiazide” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 832 patents, we discovered top 241 key players by total patent application. Novartis AG, Boehringer Ingelheim Pharma GmbH, Boehringer Ingelheim International GmbH are dominant in this area. They take 24.40% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 110
Austria
Patent: 50
Rheinland-Pfalz, Germany
Patent: 43
South Korea
Patent: 25
New Jersey, United States
Patent: 23
Czechia
Patent: 18
Maharashtra, India
Patent: 16
California, United States
Patent: 15
Switzerland
Patent: 14
New Jersey, United States
Patent: 13
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 2 start-ups by total patent application.
STARTUP
DUBLIN, Ireland
Patent: 3
STARTUP
Novitium Pharma LLC
New Jersey, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 67 patents applied in the last 5 years. We discover 49 most active companies in this area. The fast-growing Changzhou Pharmaceutical Factory Co., Ltd., Beijing Shijingshan Hypertension Alliance Institute, Shanghai Institute of Materia Medica Chinese Academy of Sciences take 14.93% of patent filing during this period.
Jiangsu Sheng, China
Patent: 4
Beijing Shijingshan Hypertension Alliance Institute
undefined undefined
Patent: 3
Shanghai Shi, China
Patent: 3
Jiangsu Guangcheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
undefined undefined
Patent: 2
STARTUP
Novitium Pharma LLC
New Jersey, United States
Patent: 2
Jiangsu Sheng, China
Patent: 2
United States
Patent: 2
Rheinland-Pfalz, Germany
Patent: 1
Shandong Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 67 patents in last 5 years, we discover 35 new entrants. Beijing Shijingshan Hypertension Alliance Institute, Nanping People's Hospital of Fujian Province (Nanping Traditional Chinese Medicine Hospital of Fujian Province), Novitium Pharma LLC are the most active new entrants in this area.
Beijing Shijingshan Hypertension Alliance Institute
undefined undefined
Patent: 3
undefined undefined
Patent: 2
STARTUP
Novitium Pharma LLC
New Jersey, United States
Patent: 2
Jiangsu Sheng, China
Patent: 2
United States
Patent: 2
Jiangsu Guangcheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Shandong Sheng, China
Patent: 1
Guangxi Medical University Ruigu Medical Laboratory Co., Ltd.
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Anhui Sheng, China
Patent: 1
Rundu Pharmaceutical (Jingmen) Co., Ltd.
Hubei Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 50 patents, we discovered top 20 universities and scientific research institutions by total patent application. University of South Florida, China Pharmaceutical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 32.00% of the total patent filing.
United States
Patent: 6
Jiangsu Sheng, China
Patent: 4
Shanghai Shi, China
Patent: 4
Hubei Sheng, China
Patent: 3
Ukraine
Patent: 2
Beijing Shi, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Taiwan Province, China
Patent: 1
Shanghai Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: